March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke ...
March 5, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
March 6, 2024 — This year’s Healthcare Information and Management Systems Society HIMSS Global Conference and Exhibition ...
March 1, 2024 — Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration (FDA) ...
March 1, 2024 — Prenatal stress is a potential risk factor for cardiovascular disease in offspring later in life. In a ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 1, 2024 — Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict ...
February 29, 2024 — The American College of Cardiology (ACC) will soon be holding its ACC 73rd Annual Scientific Session ...
PLEASE NOTE: This webinar has been postponed to a later date. A new date will be posted in the coming days. On March 25 ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image ...
February 28, 2024 — New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center ...
February 28, 2024 — Artificial intelligence (AI) may transform cardiovascular medicine. For now, though, many challenges ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
February 28, 2024 — Royal Philips has announced the proposal to appoint Charlotte Hanneman as member of the Board of ...
February 27, 2024 — Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the ...
February 27, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...
March 05, 2024
